165 related articles for article (PubMed ID: 21345168)
1. Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease.
Heneka MT; Kummer MP; Weggen S; Bulic B; Multhaup G; Münter L; Hüll M; Pflanzner T; Pietrzik CU
Curr Alzheimer Res; 2011 Mar; 8(2):115-31. PubMed ID: 21345168
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.
Sastre M; Dewachter I; Rossner S; Bogdanovic N; Rosen E; Borghgraef P; Evert BO; Dumitrescu-Ozimek L; Thal DR; Landreth G; Walter J; Klockgether T; van Leuven F; Heneka MT
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):443-8. PubMed ID: 16407166
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.
Hirohata M; Ono K; Yamada M
Curr Pharm Des; 2008; 14(30):3280-94. PubMed ID: 19075706
[TBL] [Abstract][Full Text] [Related]
6. Disease-modifying therapies in Alzheimer's disease: how far have we come?
Hüll M; Berger M; Heneka M
Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
Townsend KP; Praticò D
FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
[TBL] [Abstract][Full Text] [Related]
8. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
[TBL] [Abstract][Full Text] [Related]
9. Is it All Said for NSAIDs in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake.
Sanz-Blasco S; Calvo-Rodriguez M; Caballero E; Garcia-Durillo M; Nunez L; Villalobos C
Curr Alzheimer Res; 2018; 15(6):504-510. PubMed ID: 29283047
[TBL] [Abstract][Full Text] [Related]
10. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
[TBL] [Abstract][Full Text] [Related]
11. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
12. Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases.
Lleo A; Galea E; Sastre M
Cell Mol Life Sci; 2007 Jun; 64(11):1403-18. PubMed ID: 17447008
[TBL] [Abstract][Full Text] [Related]
13. Gamma-secretase modulation with Abeta42-lowering nonsteroidal anti-inflammatory drugs and derived compounds.
Czirr E; Weggen S
Neurodegener Dis; 2006; 3(4-5):298-304. PubMed ID: 17047371
[TBL] [Abstract][Full Text] [Related]
14. Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment?
Rampa A; Gobbi S; Belluti F; Bisi A
Curr Top Med Chem; 2013; 13(15):1879-904. PubMed ID: 23931436
[TBL] [Abstract][Full Text] [Related]
15. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
[TBL] [Abstract][Full Text] [Related]
16. Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Curr Med Chem; 2011; 18(35):5430-47. PubMed ID: 22087836
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
Halliday G; Robinson SR; Shepherd C; Kril J
Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
[TBL] [Abstract][Full Text] [Related]
18. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.
Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W
Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
20. Gamma-secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective.
Peretto I; La Porta E
Curr Top Med Chem; 2008; 8(1):38-46. PubMed ID: 18220931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
